MedPath

Ultiva

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for .  Initial U.S. Approval: 1996

Approved
Approval ID

8b4c8696-e23e-4c51-a4d2-babab5bd945a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2023

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Remifentanil Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72078-034
Application NumberNDA020630
Product Classification
M
Marketing Category
C73594
G
Generic Name
Remifentanil Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 15, 2022
FDA Product Classification

INGREDIENTS (3)

Remifentanil HydrochlorideActive
Quantity: 1 mg in 1 mL
Code: 5V444H5WIC
Classification: ACTIM
GlycineInactive
Quantity: 15 ug in 1 mL
Code: TE7660XO1C
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT

Remifentanil Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72078-035
Application NumberNDA020630
Product Classification
M
Marketing Category
C73594
G
Generic Name
Remifentanil Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 15, 2022
FDA Product Classification

INGREDIENTS (3)

Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
Remifentanil HydrochlorideActive
Quantity: 1 mg in 1 mL
Code: 5V444H5WIC
Classification: ACTIM
GlycineInactive
Quantity: 15 ug in 1 mL
Code: TE7660XO1C
Classification: IACT

Remifentanil Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72078-036
Application NumberNDA020630
Product Classification
M
Marketing Category
C73594
G
Generic Name
Remifentanil Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 15, 2022
FDA Product Classification

INGREDIENTS (3)

Remifentanil HydrochlorideActive
Quantity: 1 mg in 1 mL
Code: 5V444H5WIC
Classification: ACTIM
GlycineInactive
Quantity: 15 ug in 1 mL
Code: TE7660XO1C
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ultiva - FDA Drug Approval Details